Long-term follow-up of patients treated with intermittent hormone therapy for advanced prostate cancer

Prostate Journal

Volumn 1, Issue 3, 1999, Pages 138-143

  Hruby, George ^a   Gurney, Howard ^a   Turner, Sandra ^a   Berry, Martin ^b   Harnett, Paul ^a   Gebski, Val ^a,c  

^a WESTMEAD HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001684375     PISSN: 10955100     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1411.1999.09927.x     Document Type: Article

References (10)

1. Herr HW, Kornblith AB, Ofman U. (1993) A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 71: 1143-1150.
2. Hillner BE, McLeod DG, Crawford ED, Bennett CL. (1995) Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology 45: 633-640.
3. Noble R. (1997) Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 37: 82-94.
4. Klotz LH, Herr HW, Morse MJ, Whitmore WF. (1986) Intermittent endocrine therapy for advanced prostate cancer. Cancer 58: 2546-2550.
5. Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D. (1990) Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res. 50: 2275-2282.
6. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. (1993) Effects of intermittent androgen suppression on androgen-dependent tumors. Cancer 71: 2782-2790.
7. Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD, and Akakura K. (1995) Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report. Urology 45: 839-844.
8. Higano CS, Ellis W, Russell K, Lange PH. (1996) Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot study. Urology 48: 800-804.
9. Horwich A, Huddart RA, Gadd J, et al. (1998) A pilot study of intermittent androgen deprivation in advanced prostate cancer. Br. J. Urol. 81: 96-99.
10. Oliver RTD, Williams G, Paris AM, Blandy JP. (1997) Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer. Urology 49: 79-82.